Coverage / MCK / Trade Card

MCK

McKesson Corp

BUY Analysis generated 2026-10-04 Market data as of 2026-11-12 Market data 3 days old USD 1077.05 Healthcare - Medical - DistributionREDUCE ZONE
ACTIONABLEMethodology gates passed
78

Position levels

Currenttoday
USD 1077.05
Buy <=wait / entry
USD 838.33
Trim >=take some off
USD 975.00
Thesis breakThe thesis would be invalidated by a downgrade of the long-term 13% to 16% adjus...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case50%100 / 10050.0
Base case45%62 / 10027.9
Bear case5%10 / 1000.5
Weighted conviction78 / 100 - BUY

Top risks

  • M&A activity including acquisition of Precision Medicine Group and contributions from PRISM and Core Ventures acquisitions driving 13% of Oncology segment revenue growth
  • Strategic partnership extension with CVS Health for pharmaceutical distribution
  • $2.25 billion accelerated share repurchase program initiated with $5.0 billion increase to total authorization reaching $7.7 billion
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.

\n